Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient blood management in general intensive care patients.

Intensive care medicine·2026
Same author

Defining a fibrinogen-to-factor XIII replacement ratio in an in-vitro model of dilutional coagulopathy.

Thrombosis research·2026
Same author

Long-distance trail running induces functional iron deficiency driven by inflammation.

Blood advances·2026
Same author

Clinical relevance of circulating blood microaggregates and reactivation of Epstein Barr Virus in long-term Post-CoVID syndrome patients.

Scientific reports·2026
Same author

Differences in the Phenotype of Bacterial and Viral Sepsis-A Prospective, Multicenter, Observational Study.

Viruses·2025
Same author

Preoperative anemia, transfusions and survival in colorectal cancer surgery-A retrospective study.

Wiener klinische Wochenschrift·2025
Same journal

Necrotizing fasciitis of the thigh-a devastating sign of intestinal perforation.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Regenerative therapies in rehabilitation with interfaces with occupational medicine, geriatrics, and oncology: the example of extracorporeal shock wave therapy.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Cerebral toxoplasmosis in patients with peripheral B-cell lymphoma : A case series and a literature review.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Post-pandemic rebound of rotavirus and adenovirus in pediatric gastroenteritis: a 6-year antigen-based surveillance study from Turkey.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Neuroaxis involvement in Chikungunya virus infection: a retrospective case series.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

A complicated case of a spinal Scedosporium apiospermum infection with a favorable outcome-case report.

Wiener medizinische Wochenschrift (1946)·2026
See all related articles

Related Experiment Videos

[Anticoagulation in critically ill patient].

Dietmar Fries1

  • 1Klinische Abteilung für Allgemeine und Chirurgische Intensivmedizin, Universitätsklinik für Anästhesie und Allgemeine Intensivmedizin, Medizinische Universität Innsbruck, Innsbruck, Austria. dietmar.fries@i-med.ac.at

Wiener Medizinische Wochenschrift (1946)
|November 10, 2009
PubMed
Summary
This summary is machine-generated.

Deep vein thrombosis (DVT) affects up to 60% of critically ill patients. Anticoagulation is recommended for severe sepsis or septic shock, with careful monitoring and adjusted dosing for intensive care unit (ICU) patients.

Related Experiment Videos

Area of Science:

  • Critical Care Medicine
  • Hematology
  • Pharmacology

Background:

  • Deep vein thrombosis (DVT) is a significant risk in critically ill patients, with incidence rates potentially reaching 60%.
  • Severe sepsis and septic shock necessitate anticoagulation according to Surviving Sepsis Campaign guidelines, provided no contraindications exist.
  • Understanding risk factors and prophylaxis is crucial for managing thromboembolic events in intensive care settings.

Purpose of the Study:

  • To review risk factors for thromboembolic events in critically ill patients.
  • To discuss non-pharmacological and pharmacological prophylaxis strategies for DVT.
  • To explore methods for monitoring anticoagulation and address administration challenges in the ICU.

Main Methods:

  • Review of risk factors for thromboembolic events in critical illness.
  • Discussion of non-pharmacological and pharmacological thrombosis prophylaxis.
  • Analysis of anticoagulation monitoring methods.

Main Results:

  • Subcutaneous low molecular weight heparin (LMWH) may have reduced bioavailability and efficacy in ICU patients due to peripheral vasoconstriction, edema, shock, and catecholamine use.
  • Dosing of argatroban, a direct thrombin inhibitor, is dependent on illness severity (SAPS II score) and can be up to 10 times lower than in non-critically ill patients.

Conclusions:

  • Optimizing anticoagulation in critically ill patients requires consideration of specific physiological challenges in the ICU.
  • Adjusted dosing strategies and careful monitoring are essential for effective and safe anticoagulation in this population.
  • Alternative anticoagulants or administration routes may be necessary when standard methods are compromised.